Streetbeat News

Analyst Ratings

MORF

Morphic Holding (NASDAQ:MORF) has received mixed analyst ratings in the last quarter, with 1 bullish, 1 somewhat bullish, and 2 indifferent ratings. The average price target is $55.25, indicating potential upside from the current price of $22.82. However, this average has decreased by 29.77% from the previous average price target of $78.67.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 1:00 pm

RVTY

In the last quarter, Revvity (NYSE:RVTY) received 3 somewhat bullish and 2 indifferent ratings from analysts. The company's average 12-month price target is $137.0, an increase of 0.24% from the previous average price target of $136.67.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 1:00 pm

ARRY

Analysts have provided various ratings for Array Technologies (NASDAQ:ARRY) within the last quarter, with a total of 3 bullish, 3 somewhat bullish, and 2 somewhat bearish ratings. The company has an average 12-month price target of $29.0, an increase of 10.48% from the previous average price target of $26.25.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 1:00 pm

SHO

In the last quarter, Sunstone Hotel Invts (NYSE:SHO) received two indifferent and two somewhat bearish analyst ratings. The average 12-month price target for the stock, according to four analysts, is $9.25, representing a 3.85% decrease from the previous average price target of $9.62.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 1:00 pm

VICI

JMP Securities analyst Mitch Germain has reiterated a Market Outperform rating on VICI Props (NYSE:VICI) and maintained a $38 price target.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 12:57 pm

ASNS

GRTS

PTON

RNAZ

Several stocks are experiencing significant pre-market trading movements. Gritstone bio, Inc. (GRTS) shares rose 37% after the company was awarded a BARDA contract for a COVID-19 vaccine study valued at up to $433 million. TransCode Therapeutics, Inc. (RNAZ) shares gained 23% after pricing its $8 million public offering. Actelis Networks, Inc. (ASNS) shares surged 22.4% after achieving Third Party Validation for FIPS cyber protection standard. Peloton Interactive, Inc. (PTON) shares climbed 12.3% after announcing a five-year deal with Lululemon Athletica Inc (LULU).

Portfolio Pulse from Lisa Levin

September 28, 2023 | 12:54 pm

GRTS

Gritstone Bio Inc (NASDAQ:GRTS) has received a contract worth up to $433 million from the Biomedical Advanced Research and Development Authority (BARDA) to conduct a Phase 2b study of its self-amplifying mRNA (samRNA) vaccine candidate for COVID-19. The study, part of the U.S. Department of Health and Human Services' 'Project NextGen', will involve 10,000 participants and is expected to begin in Q1 2024. Following the news, GRTS shares rose 33.60% in premarket trading.

Portfolio Pulse from Vandana Singh

September 28, 2023 | 12:54 pm

MODG

Morgan Stanley analyst Megan Alexander has initiated coverage on Topgolf Callaway Brands (NYSE:MODG) with an Underweight rating and a price target of $12.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 12:54 pm

MRTX

JMP Securities analyst Silvan Tuerkcan has reiterated a Market Outperform rating on Mirati Therapeutics (NASDAQ:MRTX) and maintained a $58 price target.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 12:53 pm

META

JMP Securities analyst Andrew Boone has reiterated a Market Outperform rating on Meta Platforms (NASDAQ:META) and maintained a price target of $380.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 12:51 pm